SCHEMBL7076732

SCHEMBL7076732

C[S+]([O-])CCCn1cncc1-c1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 8/20 0.43
CYP11B2 P19099 8/20 0.43
IDO1 P14902 2/20 0.38
MAPK13 O15264 7/20 0.34
MAPK12 P53778 7/20 0.34
MAPK11 Q15759 7/20 0.34
MAPK14 Q16539 7/20 0.34
ALDH1A1 P00352 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAP4K4 O95819 2/20 0.33
MAPK9 P45984 2/20 0.33
CSNK1A1 P48729 2/20 0.33
CSNK1D P48730 2/20 0.33
MAP4K5 Q9Y4K4 2/20 0.33
CDC42BPA Q5VT25 1/20 0.33
AURKB Q96GD4 1/20 0.33
PRKD3 O94806 1/20 0.32
FRK P42685 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27550009 0.73 CYP11B1 (0.56) CYP11B1CYP11B2IDO1
SCHEMBL8156007 0.72 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14MAP4K4
SCHEMBL4593524 0.71 MAPK13 (0.42) CYP11B1CYP11B2IDO1MAPK13MAPK12
SCHEMBL7748830 0.69 NFATC1 (0.58) MAPK13MAPK12MAPK11MAPK14GSK3B
SCHEMBL593796 0.68 CYP11B1 (0.58) CYP11B1CYP11B2IDO1ALDH1A1RAB9A
SCHEMBL27984310 0.67 CYP11B1 (0.51) CYP11B1CYP11B2IDO1ALDH1A1RAB9A
SCHEMBL10983627 0.66 IDO1 (0.44) CYP11B1CYP11B2IDO1MAPK14ALDH1A1
SCHEMBL15653534 0.66 CYP11B1 (0.54) CYP11B1CYP11B2IDO1ALDH1A1
Morpholine SCHEMBL7748831 0.65 CYP11B1 (0.42) CYP11B1CYP11B2IDO1MAPK13MAPK12
SCHEMBL1947042 0.65 CYP11B1 (0.58) CYP11B1CYP11B2IDO1MAPK13MAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889888-A4 NOVEL TREATMENT FOR CNS INJURIES SMITHKLINE BEECHAM CORP (US) 2003-01-08 EP disclosed
US-6150557-A REACTING COMPOUND CONTAINING SECONDARY AMIDE GROUPS WITH BENZENESULFINIC ACID OR ITS DERIVATIVE IN PRESENCE OF ACID CATALYST SMITHKLINE BEECHAM CORPORATION (US) 2000-11-21 US disclosed
EP-0889888-A1 NOVEL TREATMENT FOR CNS INJURIES SMITHKLINE BEECHAM CORPORATION (US) 1999-01-13 EP disclosed
WO-1997035856-A1 NOVEL TREATMENT FOR CNS INJURIES SMITHKLINE BEECHAM CORPORATION (US) 1997-10-02 WO disclosed